Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

BENEDETTA CONTE; M BRUZZONE; M LAMBERTINI; F POGGIO; C BIGHIN; E BLONDEAUX; LAURENTIIS M DE; E VALLE; F COGNETTI; C NISTICÒ; PLACIDO S DE; O GARRONE; T GAMUCCI; F MONTEMURRO; F PUGLISI; B CARDINALI; P FREGATTI; L MIGLIETTA; F BOCCARDO; I M CEPP; MASTRO L DEL

Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

BENEDETTA CONTE
, M BRUZZONE
, M LAMBERTINI
, F POGGIO
, C BIGHIN
, E BLONDEAUX
, LAURENTIIS M DE
, E VALLE
, F COGNETTI
, C NISTICÒ
, PLACIDO S DE
, O GARRONE
, T GAMUCCI
, F MONTEMURRO
, F PUGLISI
, B CARDINALI
, P FREGATTI
, L MIGLIETTA
, F BOCCARDO
, I M CEPP

MASTRO L DEL

Department of Translational Medicine

Research output: Contribution to journal › Article

Original language	English
Journal	European Journal of Cancer
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://hdl.handle.net/11579/192911

Cite this

CONTE, BENEDETTA., BRUZZONE, M., LAMBERTINI, M., POGGIO, F., BIGHIN, C., BLONDEAUX, E., DE, LAURENTIIS. M., VALLE, E., COGNETTI, F., NISTICÒ, C., DE, PLACIDO. S., GARRONE, O., GAMUCCI, T., MONTEMURRO, F., PUGLISI, F., CARDINALI, B., FREGATTI, P., MIGLIETTA, L., BOCCARDO, F., ... DEL, MASTRO. L. (2020). Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial. European Journal of Cancer. https://hdl.handle.net/11579/192911

@article{260072710b5f41e68f37a8c85eb8cac8,

title = "Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial",

author = "BENEDETTA CONTE and M BRUZZONE and M LAMBERTINI and F POGGIO and C BIGHIN and E BLONDEAUX and DE, \{LAURENTIIS M\} and E VALLE and F COGNETTI and C NISTIC{\`O} and DE, \{PLACIDO S\} and O GARRONE and T GAMUCCI and F MONTEMURRO and F PUGLISI and B CARDINALI and P FREGATTI and L MIGLIETTA and F BOCCARDO and CEPP, \{I M\} and DEL, \{MASTRO L\}",

year = "2020",

language = "English",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

CONTE, BENEDETTA, BRUZZONE, M, LAMBERTINI, M, POGGIO, F, BIGHIN, C, BLONDEAUX, E, DE, LAURENTIISM, VALLE, E, COGNETTI, F, NISTICÒ, C, DE, PLACIDOS, GARRONE, O, GAMUCCI, T, MONTEMURRO, F, PUGLISI, F, CARDINALI, B, FREGATTI, P, MIGLIETTA, L, BOCCARDO, F, CEPP, IM & DEL, MASTROL 2020, 'Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial', European Journal of Cancer. <https://hdl.handle.net/11579/192911>

TY - JOUR

T1 - Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

AU - CONTE, BENEDETTA

AU - BRUZZONE, M

AU - LAMBERTINI, M

AU - POGGIO, F

AU - BIGHIN, C

AU - BLONDEAUX, E

AU - DE, LAURENTIIS M

AU - VALLE, E

AU - COGNETTI, F

AU - NISTICÒ, C

AU - DE, PLACIDO S

AU - GARRONE, O

AU - GAMUCCI, T

AU - MONTEMURRO, F

AU - PUGLISI, F

AU - CARDINALI, B

AU - FREGATTI, P

AU - MIGLIETTA, L

AU - BOCCARDO, F

AU - CEPP, I M

AU - DEL, MASTRO L

PY - 2020

Y1 - 2020

UR - https://iris.uniupo.it/handle/11579/192911

M3 - Article

SN - 0959-8049

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

UN SDGs

Access to Document

Other files and links

Cite this